PSMA-Directed Radioligand Therapy for Metastatic Prostate Cancer
Prostate cancer is the leading cause of total years of life lost due to cancer in men, despite developments in treatment and technology. Improved outcomes and novel therapy concepts, such as theranostics, are urgently needed. A typical example of theranostics, defined as a combination of therapy and...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2023.18.130 |